Back

Non-progressors to cardiac resynchronization therapy show long-term mortality benefit compared to progressors

27 August 2023 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Options for advanced heart failure Cardiac Resynchronisation Therapy (CRT) ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Anett Behon

Semmelweis University Heart and Vascular Center, Budapest (Hungary)

7 More presentations in this session

Presentation thumbnail
A multisensory algorithm for detection of upcoming congestion in chronic heart failure patients.
Ms M. Feijen (Leiden, NL)
Abstract Slides Video
Presentation thumbnail
Prognostic role of data transmitted by implanted cardiac electric devices in patients with advanced heart failure referred for heart transplantation
Doctor A. Aloisio (Bologna, IT)
Abstract Slides Video
Presentation thumbnail
A systematic review and meta-analysis of cardiac resynchronization therapy in inotrope-dependent heart failure: an update
Doctor N. Al-Shakarchi (Rochester, US)
Abstract Slides Video
Presentation thumbnail
Sex-related differences on short-term prognosis in patients with acute myocardial infarction related cardiogenic shock receiving Impella support in Japan
Doctor M. Nakamura (Toyama, JP)
Abstract Slides Video
Presentation thumbnail
Association between aortic valve opening during exercise and right ventricular reserve in patients with left ventricular assist device
Doctor S. Takenaka (Sapporo, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Options for advanced heart failure

The Event

Event poster

ESC Congress 2023

27 August 2023 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Re-classification of response to cardiac resynchronization therapy: the long-term effect of echocardiographic non-progression
thumbnail
Congress Presentation
Long-term outcome in non-progressors to cardiac resynchronization therapy
thumbnail
Congress Presentation
Cardiac resynchronization therapy - beyond ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources